Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2025; 71(1): 12-19


RELATIONSHIP BETWEEN LIPID PROFILE AND VITAMIN D IN OBESE ADOLESCENTS WITH HYPOTHALAMIC DYSFUNCTION

O.V. Bolshova, T.M. Malinovska, D.A. Kvachenyuk, N.A. Sprinchuk, I.V. Lukashuk, V.G. Pakhomova, V.A. Muz

    State Institution “V.P. Komisarenko Institute of Endocrinology and Metabolism of the National Academy of Medical Sciences of Ukraine”, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz71.01.012


Abstract

Vitamin D deficiency is quite common in pediatric practice, including in overweight/obese patients. Hypothalamic dysfunction in children and adolescents is characterized by excess body weight(BW)/obesity of various degrees, and cardiovascular disorders. Several studies demonstrate an inverse relationship between serum 25-hydroxyvitamin D (25OH)D levels and obesity and insulin resistance. The aim of our study was to examine the relationship between vitamin D status and lipid profile in adolescents with hypothalamic dysfunction and overweight/obesity. 87 children and adolescents with hypothalamic dysfunction (40 boys and 47 girls) were examined. 39 patients (44.8%) were overweight; 23 (26.4%), 16 (18.4%) and 9 (10.4%) people had obesity of the Ist, 2dn, and 3rd degree, respectively. Hypovitaminosis D was established in 88.5% of patients. A comparative analysis of serum 25(OH)D depending on the severity of obesity showed a decrease in its level in patients with excess BW - 69.30 ± 5.14 nmol/l and 1st-degree obesity – 52.60 ± 4.17 nmol/l and significant vitamin D deficiency in persons with the 2nd and 3rd-degree obesity (36.20 ± 3.75 nmol/l, 23.10 ± 3.12 nmol/l, respectively). It has been shown that a decrease in serum 25(OH)D levels is associated with a decrease in HDLC levels, while levels of total cholesterol (TC), triglycerides, LDL-C, and the atherogenicity index reliably increase. The relationship between the levels of vitamin D and the HOMAIR, and leptin and insulin levels is shown. In patients with hypothalamic dysfunction and excess BW/obesity, body mass index is likely to be associated with serum 25(OH)D. The most significant changes in lipid fractions were observed in patients with 3rd-degree obesity, who had the lowest serum 25(OH) D. In patients with hypothalamic dysfunction, an increase in the atherogenicity index and triglyceride levels is observed, corresponding to the rise in obesity degree and a decrease of serum 25(OH)D. It was established that in patients with hypothalamic dysfunction against the background of vitamin D deficiency, there is a reliable increase in the level of TC and HDL-C to the control group in the 3rd degree of obesity and a reliable decrease in HDL-C in the 2nd and 3rd degree of obesity. An increase in leptin and insulin levels occurs already under excess BW, and their levels prolong the increase with increasing obesity degree and vitamin D deficiency. Against the background of hypovitaminosis D, the levels of leptin and insulin in patients with hypothalamic dysfunction exceed the normative indicators by 3.5-7 times with 2nd degree of obesity and 3.5-4 times – with 3rd degree of obesity. In adolescents with hypothalamic dysfunction, a reliable increase (by 2-6 times) of the HOMA-IR is observed in parallel with an increase in the degree of obesity and vitamin D deficiency.

Keywords: vitamin D; lipid profile; leptin; insulin; insulin resistance index; hypothalamic dysfunction; obesity; adolescents.

References

  1. Qi KJ, Zhao ZT, Zhang W, Yang F. The impacts of vitamin D supplementation in adults with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2022 Oct 5;13:1033026. CrossRef PubMed PubMedCentral
  2. Fiamenghi VI, Mello ED. Vitamin D deficiency in children and adolescents with obesity: a meta-analysis. J Pediatr (Rio J). 2021 May-Jun;97(3):273-9. CrossRef PubMed PubMedCentral
  3. Corsello A, Macchi M, D'Oria V, Pigazzi C, Alberti I, Treglia G, De Cosmi V, Mazzocchi A, Agostoni C, Milani GP. Effects of vitamin D supplementation in obese and overweight children and adolescents: A systematic review and meta-analysis. Pharmacol Res. 2023 Jun;192:106793. CrossRef PubMed
  4. Bereket A, Kiess W, Lustig RH, Muller HL, Goldstone AP, Weiss R, Yavuz Y, Hochberg Z. Hypothalamic obesity in children. Obes Rev. 2012 Sep;13(9):780-98. CrossRef PubMed
  5. Hagău AC, Pușcaș A, Togănel R, Muntean I. Is hypovitaminosis D a risk factor for Heart failure? Life (Basel). 2023 Jan 29;13(2):372. CrossRef PubMed PubMedCentral
  6. Ballard-Hernandez J, Sall J. Dyslipidemia update. Nurs Clin North Am. 2023 Sep;58(3):295-308. 15.PMID: 37536782 Review. CrossRef PubMed
  7. Banach M, Shekoohi N, Mikhailidis DP, Lip GYH, Hernandez AV, Mazidi M. Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988). Arch Med Sci. 2022 Jan 19;18(4):912-29. CrossRef
  8. Guan CL, Liu HT, Chen DH, Quan XQ, Gao WL, Duan XY. Is elevated triglyceride/high-density lipoprotein cholesterol ratio associated with poor prognosis of coronary heart disease? A meta-analysis of prospective studies. Medicine (Baltimore). 2022 Nov 11;101(45):e31123. CrossRef PubMed PubMedCentral
  9. Kelishadi R, et al Effects of vitamin D supplementation on insulin resistance and cardiometabolic risk factors in children with metabolic syndrome: a triple-masked controlled trial. J Pediatr (Rio J). 2014. CrossRef PubMed
  10. Wu C, Song Y, Wang X. Vitamin D supplementation for the outcomes of patients with gestational diabetes mellitus and neonates: A meta-analysis and systematic review. Int J Clin Pract. 2023 Jan 14;2023:1907222. CrossRef PubMed PubMedCentral
  11. Hu Z, Cui J, Li X, Zhou Y, Cai L, Zhang S. High-density lipoprotein cholesterol in young nondiabetic coronary heart disease patients. Cardiol Res Pract. 2021 Jul 13;2021:2970568. CrossRef PubMed PubMedCentral
  12. Jin D, Zhu DM, Hu HL, Yao MN, Yin WJ, Tao RX, Zhu P. Vitamin D status affects the relationship between lipid profile and high-sensitivity C-reactive protein. Nutr Metab (Lond). 2020 Jul 14;17:57. CrossRef PubMed PubMedCentral
  13. Luo X, Zhang P, Luan Y, Cai X, He X. Effect of vitamin D supplementation on markers of cardiometabolic risk in children and adolescents: A meta-analysis of randomized clinical trials. Nutr Metab Cardiovascul Dis. 2021 Sep 22;31(10):2800. CrossRef PubMed
  14. Ströhle A. The updated recommendations of the US Institute of Medicine (IOM) on the intake of vitamin D. A critical appraisal. Med Monatsschr Pharm. 2011 Aug;34(8):291-8. [German]. PMID: 21853883.
  15. Al-Elq AH, Sadat-Ali M, Al-Turki HA, et al. Is there a relationship between body mass index and serum vitamin D levels? Saudi Med J. 2009 Dec;30(12):1542-6. PMID: 19936417
  16. Saneei P, Salehi-Abargouei A, Esmaillzadeh A. Serum 25-hydroxy vitamin D levels in relation to body mass index: a systematic review and meta-analysis.Obes Rev. 2013 May;14(5):393-404. CrossRef PubMed
  17. Khashayar P, Meybodi HR, Soltani A, Taheri E, Homami MR, Heshmat R, Dimai HP, Larijani B. Association between vitamin D levels and BMI values in an Iranian population. Clin Lab. 2014;60(3):383-9. CrossRef PubMed
  18. Francisco Pérez-Bravo, Lissette Duarte, MiguelArredon do-Olguín, et al. Vitamin D status and obesity in children from Chile. Eur J Clin Nutr. 2022 Jun;76(6):899-901. CrossRef PubMed PubMedCentral
  19. Galeazzi T, Quattrini S, Pjetraj D, et al. Vitamin D status in healthy Italian school-age children: a single-center cross-sectional study. Ital J Pediatr. 2023 Feb 22;49(1):27. CrossRef PubMed PubMedCentral
  20. Gou H, Wang Y, Liu Y, et al. Efficacy of vitamin D supplementation on child and adolescent overweight/obesity: a systematic review and meta-analysis of randomized controlled trials. Eur J Pediatr. 2023 Jan;182(1):255-64. CrossRef PubMed
  21. Wolters M, Marron M, Foraita R, et al. Longitudinal associations between vitamin D status and cardiometabolic risk markers among children and adolescents. J Clin Endocrinol Metab. 2023 Nov 17;108(12):e1731-e42. CrossRef PubMed
  22. Kelishadi R, Farajzadegan Z, Bahreynian M. Association between vitamin D status and lipid profile in children and adolescents: a systematic review and meta-analysis. Int J Food Sci Nutr. (2014)65:404-10. CrossRef PubMed
  23. Suder A, Chrzanowska M. Risk factors for abdominal obesity in children and adolescents from Сracow, Рoland (1983-2000). J Biosoc Sci. 2015;47:203. CrossRef PubMed
  24. Tamer G, Telci Caklili O, Gungor K, et al. Effect of vitamin D status on lipid profile in premenopausal women: a cross-sectional study. Cardiovascul Endocrinol. 2017 May 17;6(2):86-91. CrossRef PubMed PubMedCentral
  25. Dibaba DT. Effect of vitamin D supplementation on serum lipid profiles: a systematic review and meta-analysis. Nutr Rev. 2019 Dec 1;77(12):890-902. CrossRef PubMed
  26. Bahadorpour S, Hajhashemy Z, Saneei P. Serum 25-hydroxyvitamin D levels and dyslipidemia: a systematic review and dose-response meta-analysis of epidemiologic studies. Nutr Rev. 2022 Dec 6;81(1):1-25. CrossRef PubMed
  27. Hajhashemy Z, Tirani SA, Askari G, et al. The association between serum vitamin D levels and abnormal lipid profile in pediatrics: A GRADE-assessed systematic review and dose-response meta-analysis of epidemiologic studies. Nutr Rev. 2024 Apr 3:nuae020. CrossRef PubMed

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2025.